Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new study, neuroscientists have found that raised blood pressure and diabetes in mid-life alter brain structure to slow thinking speed and memory.

Three scientists looking at a computer screen in an open plan office
Dr Xin You Tai, DPhil student, Dr Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology and Masud Husain, Professor of Neurology and Cognitive Neuroscience

Looking at results from 22,000 volunteers in the UK Biobank who underwent brain scanning, the scientists found that raised blood pressure and diabetes significantly impaired the brain’s cognitive functions, specifically the performance of thinking speed and short-term memory.

Masud Husain, Professor of Neurology and Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences and lead investigator of the study, said, ‘For blood pressure, every mm of pressure in your arteries counts – even in people who aren’t on any treatment. For people who are on treatment, systolic blood pressures above 140 mm were associated with lower cognitive performance. The higher the pressure, the worse it is.’

Monitoring and treating even modestly raised blood pressure might make a difference to the structure of the brain and speed of thinking in mid-life, while also offering potential to reduce the risks of developing dementia later in life.
- Professor Masud Husain

The study, published in Nature Communications, shows the effects of blood pressure were strongest in people aged 44-69. Whereas in people aged above 70, the level of pressure did not have such an impact on the brain’s cognitive function.

These effects appear to be mediated by alterations in brain structure that were detected using new MRI brain scanning analysis techniques. The brain changes occurred in people with high blood pressure and diabetes, who were otherwise healthy individuals.

Some researchers have previously shown that blood pressure and diabetes in mid-life can increase the risk of developing dementia later in life. The new findings of the Oxford group reveal that these factors can also have a direct impact on cognitive performance in mid-life.

Dr. Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology at the Department of Experimental Psychology and co-author of the study, said, ‘The MRI scans show that raised blood pressure and glucose seem to alter both the grey matter and the white matter connections in the brain.’

Dr. Xin You Tai, collaborator and DPhil student at the Nuffield Department of Clinical Neurosciences, said, ‘These changes seem to have a direct impact on the speed of thinking and short-term memory.’

The findings have important implications for brain health and may help neuroscientists answer how we can keep our brains healthy and more resilient as we get older.

Similar stories

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.